Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NEOGENOMICS INC Director's Dealing 2021

Jul 15, 2021

32227_dirs_2021-07-15_8eba3671-d62b-4246-88b7-f1ce6dcbc3c2.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2021-06-18

Reporting Person: Morris Clive (President of Inivata)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-06-18 Common Stock A 10708 Acquired 10708 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-06-18 Stock Option (Right to Buy) $43.58 A 53857 Acquired 2028-06-18 Common Stock (53857.0) Direct

Footnotes

F1: On June 18, 2021, Mr. Morris was granted 53,857 stock options. The options vest ratably over the first four anniversary dates of the grant date.